Facebook
Twitter
LinkedIn
ForwardUpdate Series (2024) Lesson 20: Testosterone Replacement Therapy In Men With Prostate Cancer
Audio Lessons - Listen on-the-go for Free!
Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?
Add the Update Series Audio Lessons to Your Podcast Library Today!
Please follow the download instructions to your preferred Podcast app, located below.
Apple Podcasts
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Apple Podcasts app.
3. Click on "Library" on the bottom row of icons.
4. Click "…" on the top right corner, and select "Add a Show by URL".
5. Paste your copied personal URL and tap "Follow".
Pocket Casts
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Pocket Casts app.
3. On the “Discover” tab, paste your copied personal feed URL in the Search field and hit “Search”.
4. Click on the Update Series Podcast in search results.
5. Click "Subscribe".
*Please note that this URL is individual to you and only available to Update Series 2024 subscribers.
Instructions to stream the Update Series in other Podcast apps.
Access the Audio Lessons are also available in the AUAUniversity app and within the AUAU lesson Content page.
 |
Target Audience
- Urologist
- Resident
Learning Objectives
At the conclusion of this continuing medical education activity, the participant will be able to respond to concerns that testosterone therapy promotes prostate cancer growth, counsel patients on the risks and benefits associated with testosterone therapy, and appropriately identify potential candidates for testosterone therapy.
You may also be interested in
Education Council Disclosures
COI Review Work Group Disclosures
COI Review Work Group Disclosures
Update Series Editorial Committee Disclosures
Update Series Editorial Committee Disclosures
Author Disclosures
| Name | Company Name | Relationship Type | End Date |
| Flores, Jose M. | No relevant disclosures | ||
| Thorogood, Samantha | No relevant disclosures | ||
| Mulhall, John P. | No relevant disclosures |
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.
METHOD OF PARTICIPATION:
Participants receive 5 lessons per month for 8 months for a total of 40 lessons. Each lesson is designated for a maximum of 1.0 AMA PRA Category 1 Credit™. To earn credit, participants must read the educational material provided for each lesson, pass its corresponding online posttest with at least 80% accuracy, submit the online evaluation and claim CME.
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of a CME activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible company (formerly commercial interests) during the previous 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The AUA must determine if the individual’s relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.
MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification relevant financial relationships that result in of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
PEER REVIEW:
Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Editorial Committee.
Released date: June, 2024
Expiration date: June, 2027
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation